Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post
Binding Commitments Received for A$1.0 Million under Convertible Note Placement
next post
Yemen’s Houthis claim dozens killed in alleged US airstrike on prison holding African migrants

Related Posts

Theia In-fill – Multiple High-Grade Zones of Gold

November 18, 2025

Locksley Resources LimitedAdvances Multiple Antimony and REE Workstreams

October 3, 2025

More high-grade assays pave way for resource at...

June 10, 2025

Precious Metals & Critical Minerals Hybrid Investor Conference...

May 17, 2025

High Grade surface silver results up to 920g/t...

May 15, 2025

Syntheia Signs Definitive Agreement for Call Center Acquisition

July 5, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (257)
    • Investing (1,578)
    • Stocks (206)
    • World News (648)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved